Tyler Bussian
Stock Analyst at Brookline Capital
(0.18)
# 4,261
Out of 4,905 analysts
5
Total ratings
25%
Success rate
-21.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tyler Bussian
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Buy | $9 | $1.61 | +459.01% | 1 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $63 | $8.45 | +645.56% | 1 | Jul 8, 2024 | |
| IMUX Immunic | Initiates: Buy | $10 | $0.93 | +973.42% | 1 | Apr 5, 2024 | |
| ANVS Annovis Bio | Downgrades: Hold | $9 | $2.53 | +255.45% | 2 | Feb 28, 2024 |
Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $1.61
Upside: +459.01%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $8.45
Upside: +645.56%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $10
Current: $0.93
Upside: +973.42%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $2.53
Upside: +255.45%